Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis
International Journal of Heart Failure · 2024 · 6 (1) · 36
DOI: 10.36628/ijhf.2023.0031 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Heart Failure, 2024. Verfasst von Spencer C Lacy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Loyola University Medical Center, Maywood, IL, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Loyola University Medical Center, Maywood, IL, USA.
- Division of Cardiovascular Medicine, Loyola University Medical Center, Maywood, IL, USA.
ORCID-Profile: Spencer C Lacy, Menhel Kinno, Mingxi D Yu
Zitieren
APA
Lacy, S. C., Kinno, M., Joyce, C., & Yu, M. D. (2024). Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis. International Journal of Heart Failure, 6(1), 36. https://doi.org/10.36628/ijhf.2023.0031
Vancouver
Lacy SC, Kinno M, Joyce C, Yu MD. Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis. International Journal of Heart Failure. 2024;6(1):36. doi:10.36628/ijhf.2023.0031
BibTeX
@article{Lacy2024,
author = {Lacy, Spencer C and Kinno, Menhel and Joyce, Cara and Yu, Mingxi D},
title = {Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis},
journal = {International Journal of Heart Failure},
year = {2024},
volume = {6},
number = {1},
pages = {36},
doi = {10.36628/ijhf.2023.0031}
}
EUVIMED